Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma)

Lauren Singer,Jorie Singer,Craig Horbinski,Marta Penas-Prado,Rimas V. Lukas
DOI: https://doi.org/10.1097/nrl.0000000000000572
2024-05-27
The Neurologist
Abstract:Introduction: Solitary fibrous tumors (SFTs) of the central nervous system represent a unique entity with limited data on best treatment practices. Case Report: Here, we present a case of multiply recurrent central nervous system SFT treated with radiation and immunotherapy. Immunotherapy was chosen based on mutations of genes encoding DNA repair enzymes detected through next-generation sequencing of the tumor, DNA polymerase epsilon catalytic subunit ( POLE ) and mutL homolog 1. The use of radiation and immunotherapy led to slight shrinkage and no recurrence of the tumor for over 2 years. Conclusion: The presence of somatic DNA repair enzyme gene mutations in SFT may suggest a benefit from a combination of radiotherapy and immunotherapy. This may serve as a biomarker for guiding management in patients with this rare tumor.
clinical neurology
What problem does this paper attempt to address?